ERBB2 and breast carcinoma: The current clinical treatment plan for breast cancer varies depending on characteristics of the primary tumor divided into four major molecular subtypes (LumA, LumB, Triple-negative/basal-like, and HER2 type) and two less common subtypes (Normal-like and Claudin-low) [1–3].